Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that diagnosing and treating Congenital Adrenal Hyperplasia is complex and requires a team approach due to its effects on the skin and other symptoms.

Spironolactone harms fish reproduction and is more potent in fish than invertebrates, needing environmental monitoring.

Lysophosphatidic acid is important for skin health and disease, and could be a target for new skin disorder treatments.

The spiny mouse is a unique menstruating rodent that can help us understand menstruation and reproductive disorders.

Some growth factors, while important for normal body functions, can cause diseases when not regulated properly.

Hormonal imbalances, often indicating conditions like PCOS, are common in women with hard-to-treat acne, and a treatment approach addressing these imbalances may be needed.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

All treatments reduce hair growth; low dose flutamide most effective with fewer side effects.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

The oral glucose tolerance test is effective in detecting abnormal glucose tolerance in Indian women with PCOS.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.

Most patients experienced hirsutism again after stopping hormone treatment, indicating long-term treatment is needed to maintain results.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Acne is an important sign of androgen excess disorders in women.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

Topical eye β-blockers may cause hair loss.

Juniperus plants contain compounds with potential for developing various medical treatments.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.